Dixon Hubard Feinour & Brown’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $10.2M | Sell |
57,270
-1,665
| -3% | -$297K | 1.21% | 22 |
|
|
2022
Q1 | $10.4M | Sell |
58,935
-2,570
| -4% | -$437K | 1.05% | 30 |
|
|
2021
Q4 | $10.5M | Buy |
61,505
+26,808
| +77% | +$4.39M | 1.01% | 34 |
|
|
2021
Q3 | $5.6M | Sell |
34,697
-2,518
| -7% | -$430K | 1.19% | 27 |
|
|
2021
Q2 | $6.13M | Sell |
37,215
-41,271
| -53% | -$6.83M | 1.28% | 26 |
|
|
2021
Q1 | $12.3M | Buy |
78,486
+38,273
| +95% | +$6.19M | 1.51% | 19 |
|
|
2020
Q4 | $5.99M | Hold |
40,213
| – | – | 1.54% | 22 |
|
|
2020
Q3 | $5.99M | Sell |
40,213
-2,339
| -5% | -$346K | 1.54% | 22 |
|
|
2020
Q2 | $6.25M | Buy |
42,552
+1,484
| +4% | +$216K | 1.62% | 23 |
|
|
2020
Q1 | $5.38M | Buy |
41,068
+100
| +0.2% | +$14.2K | 1.82% | 20 |
|
|
2019
Q4 | $5.98M | Sell |
40,968
-700
| -2% | -$94.9K | 1.55% | 23 |
|
|
2019
Q3 | $5.39M | Sell |
41,668
-848
| -2% | -$112K | 1.49% | 23 |
|
|
2019
Q2 | $5.92M | Buy |
42,516
+20
| +0% | +$2.77K | 1.68% | 20 |
|
|
2019
Q1 | $5.94M | Buy |
42,496
+188
| +0.4% | +$25.2K | 1.79% | 17 |
|
|
2018
Q4 | $5.46M | Buy |
42,308
+1,234
| +3% | +$172K | 2.02% | 15 |
|
|
2018
Q3 | $5.67M | Sell |
41,074
-1,333
| -3% | -$177K | 1.57% | 24 |
|
|
2018
Q2 | $5.15M | Sell |
42,407
-38,923
| -48% | -$4.86M | 1.5% | 24 |
|
|
2018
Q1 | $10.4M | Sell |
81,330
-3,467
| -4% | -$469K | 2.91% | 2 |
|
|
2017
Q4 | $11.8M | Buy |
84,797
+5,629
| +7% | +$784K | 3.21% | 1 |
|
|
2017
Q3 | $10.3M | Sell |
79,168
-525
| -0.7% | -$69.6K | 2.95% | 1 |
|
|
2017
Q2 | $10.5M | Sell |
79,693
-1,112
| -1% | -$142K | 3.05% | 2 |
|
|
2017
Q1 | $10.1M | Sell |
80,805
-458
| -0.6% | -$54.7K | 2.99% | 1 |
|
|
2016
Q4 | $9.36M | Sell |
81,263
-2,132
| -3% | -$246K | 2.97% | 1 |
|
|
2016
Q3 | $9.85M | Buy |
83,395
+1,045
| +1% | +$127K | 3.06% | 1 |
|
|
2016
Q2 | $9.99M | Buy |
82,350
+35,227
| +75% | +$4M | 3.19% | 1 |
|
|
2016
Q1 | $5.28M | Sell |
47,123
-750
| -2% | -$77.6K | 1.73% | 18 |
|
|
2015
Q4 | $4.92M | Buy |
47,873
+156
| +0.3% | +$15.7K | 1.56% | 25 |
|
|
2015
Q3 | $4.45M | Sell |
47,717
-855
| -2% | -$82.7K | 1.64% | 21 |
|
|
2015
Q2 | $4.73M | Sell |
48,572
-1,480
| -3% | -$148K | 1.46% | 27 |
|
|
2015
Q1 | $5.04M | Buy |
50,052
+500
| +1% | +$50.8K | 1.49% | 20 |
|
|
2014
Q4 | $5.18M | Sell |
49,552
-306
| -0.6% | -$32.2K | 1.61% | 19 |
|
|
2014
Q3 | $5.31M | Sell |
49,858
-115
| -0.2% | -$11.9K | 1.74% | 14 |
|
|
2014
Q2 | $5.23M | Hold |
49,973
| – | – | 1.71% | 18 |
|
|
2014
Q1 | $4.91M | Sell |
49,973
-2,060
| -4% | -$191K | 1.7% | 18 |
|
|
2013
Q4 | $4.77M | Sell |
52,033
-410
| -0.8% | -$37.8K | 1.76% | 16 |
|
|
2013
Q3 | $4.55M | Sell |
52,443
-2,360
| -4% | -$212K | 1.93% | 12 |
|
|
2013
Q2 | $4.71M | Buy |
+54,803
| New | +$4.65M | 2.1% | 11 |
|
Other funds holding JNJ
Dixon Hubard Feinour & Brown's JNJ Position: Q2 2022 in Review
Dixon Hubard Feinour & Brown reduced its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2022, selling an estimated $297K and leaving 57,270 shares worth $10.2M. The position accounts for 1.21% of the portfolio, ranked #22.
Dixon Hubard Feinour & Brown first reported a position in JNJ in Q2 2013 and has held it in 37 quarters since. The position peaked at $12.3M in Q1 2021. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.
- Dixon Hubard Feinour & Brown held 57,270 shares of Johnson & Johnson worth $10.2M as of Q2 2022.
- Dixon Hubard Feinour & Brown sold 1,665 Johnson & Johnson shares in Q2 2022, an estimated $297K.
- Johnson & Johnson made up 1.21% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #22 holding.
- Dixon Hubard Feinour & Brown first reported a position in Johnson & Johnson in Q2 2013 and has held it in 37 quarters since.
- Dixon Hubard Feinour & Brown's Johnson & Johnson position peaked at $12.3M in Q1 2021.
- 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.